s6y
Company name or ticker
Search
TEVA PHARMACEUTICAL INDUSTRIES LTD
DEF 14A
Definitive proxy statements
Filed
Tuesday, March 31, 2026
Period
May 28, 2026
Accession number
0001193125-26-134756
Documents
DEF 14A
DEF 14A
XBRL TAXONOMY EXTENSION SCHEMA
EX-101.SCH
On sec.gov
Filing index
All files
Complete submission text
SGML header